Our clinical evidence supported the notion that decreased HCRP-1 expression can be considered as an important prognostic marker for CRC patients who are at high risk of unfavorable survival and may play a potential role in CRC metastasis. The gene discussed is VPS37A; the disease is colorectal carcinoma.